Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICE-MRI Bladder Permeability Assay in Interstitial Cystitis
NCT05811377Phase 1Completed
- Start
- Mar 2023
- Primary completion
- May 2025
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of gadobutrol and ferumoxytol in interstitial cystitis (IC). Primary endpoint: Bladder permeability MRI assay at 90 minutes. Started Mar 2023; status: completed.
02
Drugs
gadobutrolferumoxytol
03
Conditions
interstitial cystitis (IC)
Beyond the preview
Go deeper on NCT05811377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05811377.